Professor Athimalaipet Ramanan

Honorary Professor

Paediatric Rheumatology

Level 6,
UHB Education Centre, Upper Maudlin Street BS2 8AE
(See a map)

Research summary

Randomised controlled trials of novel biological drugs in children with JIA associated uveitis. I am the Co-Chief Investigator of Sycamore Trial (RCT of adalimumab in JIA associated uveitis) funded by HTA/ARUK. I am also the Co-Chief Investigator of a trial of Tocilizumab in anti TNF refractory JIA associated uveitis.
Leading on new agents for management of refractory arthritis in collaboration with industry
Design and conduct studies in rare disease using novel study designs (Bayesian and Simon design)
Looking at diagnostic markers and new therapies for MAS or secondary HLH
Collaboration ...

Ramanan, AV, Dick, AD, Jones, AP, McKay, A, Williamson, PR, Compeyrot-Lacassagne, S, Hardwick, B, Hickey, H, Hughes, D, Woo, P, Benton, D, Edelsten, C, Beresford, MW & , 2017, ‘Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis’. New England Journal of Medicine, vol 376., pp. 1637-1646

Dick, AD, Rosenbaum, JT, Al-Dhibi, HA, Jr., RB, Brézin, AP, Chee, SP, Davis, JL, Ramanan, AV, Sonoda, K-H, Carreño, E, Nascimento, H, Salah, S, Salek, S, Siak, J, Steeples, L & , 2018, ‘Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative’. Ophthalmology, vol 125., pp. 757-773
Cann, M, Ramanan, AV, Crawford, A, Dick, AD, Clarke, SLN, Rashed, F & Guly, CM, 2018, ‘Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy’. Pediatric Rheumatology, vol 16., pp. 51